CVA Family Office’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$426K Hold
17,570
– – 0.04% 217
2026
Q1
$426K Hold
17,570
– – 0.04% 199
2025
Q4
$427K Buy
17,570
+10,275
+141% +$250K 0.05% 187
2025
Q3
$178K Hold
7,295
– – 0.02% 313
2025
Q2
$177K Hold
7,295
– – 0.02% 314
2025
Q1
$176K Hold
7,295
– – 0.03% 299
2024
Q4
$175K Hold
7,295
– – 0.03% 289
2024
Q3
$178K Buy
7,295
+4,140
+131% +$99.8K 0.03% 281
2024
Q2
$74.9K Hold
3,155
– – 0.01% 415
2024
Q1
$75.1K Buy
+3,155
New +$75.1K 0.01% 409

Other funds holding IBDS

CVA Family Office's IBDS Position: Q2 2026 in Review

CVA Family Office held its iShares iBonds Dec 2027 Term Corporate ETF (IBDS) position steady in Q2 2026 at 17,570 shares worth $426K. The position accounts for 0.04% of the portfolio, ranked #217.

CVA Family Office first reported a position in IBDS in Q1 2024 and has held it in 10 quarters since. The position peaked at $427K in Q4 2025. 416 funds tracked by Wall St. Rank hold IBDS as of Q2 2026.

  • CVA Family Office held 17,570 shares of iShares iBonds Dec 2027 Term Corporate ETF worth $426K as of Q2 2026.
  • CVA Family Office left its iShares iBonds Dec 2027 Term Corporate ETF share count unchanged in Q2 2026.
  • iShares iBonds Dec 2027 Term Corporate ETF made up 0.04% of CVA Family Office's portfolio in Q2 2026, its #217 holding.
  • CVA Family Office first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q1 2024 and has held it in 10 quarters since.
  • CVA Family Office's iShares iBonds Dec 2027 Term Corporate ETF position peaked at $427K in Q4 2025.
  • 416 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.